GGrantIndex
Sort

39,280 grants matching leukemia

Statistical Informatics for Cancer Research

$727,748
Xihong Lin · Harvard School Of Public Health · P01 · FY2008 · CA

Extent and Significance of Bacterial DNA Integrations in the Human Cancer Genome

$727,738
Julie Dunning Hotopp · University Of Maryland Baltimore · R01 · FY2020 · CA

Prevention of Heart Failure induced by Doxorubicin with Early Administration of Dexrazoxane

$727,686
Hui-Ming Chang · Univ Of Arkansas For Med Scis · R01 · FY2021 · HL

Activation of Proto-Oncogenes by Chromosomal Translocation

$727,613
Peter Aplan · Division Of Clinical Sciences - Nci · ZIA · FY2015 · CA

CD300 receptors regulate efferocytosis, importance in inflammation, cancer and autoimmunity

$727,456
John Coligan · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI

Wnt signaling in hematopoietic development

$727,312
David Traver · University Of California, San Diego · R01 · FY2023 · HL

The Evaluation of Novel Therapeutics for Genitourinary Malignancies

$727,088
William Laurence Dahut · Clinical Sciences · Z01 · FY2007 · CA

Targeting Protein Arginine Methyltransferases to Eradicate Acute Myeloid Leukemia

$727,057
Ling Li · Beckman Research Institute/City Of Hope · R01 · FY2024 · CA

Administrative Core

$727,025
Sumithra Jay Mandrekar · Mayo Clinic Rochester · U10 · FY2025 · CA

The role of adverse social-biological interactions in acute myeloid leukemia disparities

$726,828
Irum Khan · Northwestern University At Chicago · R01 · FY2025 · CA

Pharmacogenomics of Childhood Leukemia ALL

$726,561
William E. Evans · St. Jude Children'S Research Hospital · R01 · FY2016 · CA

Pharmacogenomics of Childhood Leukemia ALL

$726,540
William E. Evans · St. Jude Children'S Research Hospital · R01 · FY2017 · CA

Pharmacogenomics of Childhood Leukemia ALL

$726,520
William E. Evans · St. Jude Children'S Research Hospital · R01 · FY2018 · CA

Core 2

$726,297
Andrea Califano · Columbia University Health Sciences · U54 · FY2014 · CA

Prevention of Heart Failure induced by Doxorubicin with Early Administration of Dexrazoxane

$726,166
Hui-Ming Chang · Univ Of Arkansas For Med Scis · R01 · FY2022 · HL

Synthesis and Study of Natural and Non-natural Antiproliferative Agents

$725,971
Andrew G Myers · Harvard University · R01 · FY2019 · CA

Genome-Wide Association Study of Childhood Leukemia by Hispanic Status

$725,965
Joseph Leo Wiemels · University Of California, San Francisco · R01 · FY2014 · CA

Brain-Imaging Markers of Neurotoxicity and Long-Term Outcomes after CAR-T Cell Therapy

$725,813
Ravi Bansal · Children'S Hospital Of Los Angeles · R01 · FY2023 · CA

Immunotoxin Therapy of Solid and Hematopoietic Tumors: Preclinical Studies

$725,564
Ira Pastan · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

SAMIPS-NPC: Southern Africa Mother Infant Pertussis Study, Nasopharyngeal Carriage

$725,494
Christopher J Gill · Boston University Medical Campus · R01 · FY2019 · AI

Hematopoietic Stem Cell And Cord Blood Transplantation

$725,390
Effie W Petersdorf · Fred Hutchinson Cancer Center · U01 · FY2025 · AI

NCORP Research Base BIQSFP application

$725,002
Brad H. Pollock · Public Health Institute · UG1 · FY2021 · CA

Base-Edited Hematopoietic Stem and Progenitor Cells To Enable Safe Use Of Highly Potent CD33-Targeted Radioimmunotherapy

$724,829
Roland Bruno Walter · Fred Hutchinson Cancer Center · R01 · FY2023 · CA

Novel Cellular Therapies for Ph+ leukemia

$724,784
Richard A. Van Etten · Tufts Medical Center · R01 · FY2010 · HL

Sensitive Detection of Bacterial Contamination in Platelets

$724,627
Season S-S Wong · Lynntech, Inc. · R44 · FY2007 · HL